|
|
|
Insider
Information: |
Schenkein David P |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
178,178 |
|
Indirect Shares
|
417,826 |
|
|
Direct
Value |
$6,734,804 |
|
|
Indirect Value
|
$17,699,944 |
|
|
Total
Shares |
596,004 |
|
|
Total
Value |
$24,434,748 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-300.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2024-06-13 |
126,242 |
2024-06-13 |
349,854 |
Premium* |
|
Foundation Medicine, Inc. |
FMI |
Director |
2016-06-16 |
23,326 |
2016-06-16 |
10,508 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
|
2020-06-18 |
6,832 |
2014-12-19 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-05-31 |
21,496 |
2024-05-31 |
57,464 |
Premium* |
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-02 |
282 |
2023-09-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
155 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive OfficerOfficer |
|
2013-07-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
374,544 |
|
- |
|
FMI |
Foundation Medicine, Inc. |
Director |
|
2013-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
31,250 |
|
- |
|
FMI |
Foundation Medicine, Inc. |
Director |
|
2013-09-30 |
4 |
A |
$0.00 |
$0 |
I/I |
62,500 |
31,250 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-03-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
190 |
94,511 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2016-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
1,000 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2017-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
3,176 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-09-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
500 |
271,772 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2017-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
249,998 |
19,774 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
4,176 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-11-08 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,000 |
270,772 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2019-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,125 |
91,974 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
5,176 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2020-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,125 |
105,692 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2020-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,775 |
105,933 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
|
|
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,656 |
6,832 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2021-02-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,540) |
110,638 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,125 |
113,178 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2021-02-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(821) |
112,591 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2021-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,774 |
113,412 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2021-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,686 |
114,277 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2021-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,253 |
3,253 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,074 |
5,327 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2022-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,775 |
117,052 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2022-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,585 |
117,879 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,986 |
11,313 |
0 |
- |
|
155 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|